These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 17671656)

  • 1. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis.
    Hinchey J; Lee S; Jeon BY; Basaraba RJ; Venkataswamy MM; Chen B; Chan J; Braunstein M; Orme IM; Derrick SC; Morris SL; Jacobs WR; Porcelli SA
    J Clin Invest; 2007 Aug; 117(8):2279-88. PubMed ID: 17671656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New TB vaccines: is there a requirement for CD8 T cells?
    Boom WH
    J Clin Invest; 2007 Aug; 117(8):2092-4. PubMed ID: 17671648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice.
    Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H
    Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response.
    Kurtz S; McKinnon KP; Runge MS; Ting JP; Braunstein M
    Infect Immun; 2006 Dec; 74(12):6855-64. PubMed ID: 17030572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis.
    Hinchey J; Jeon BY; Alley H; Chen B; Goldberg M; Derrick S; Morris S; Jacobs WR; Porcelli SA; Lee S
    PLoS One; 2011 Jan; 6(1):e15857. PubMed ID: 21264335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis.
    Braunstein M; Espinosa BJ; Chan J; Belisle JT; Jacobs WR
    Mol Microbiol; 2003 Apr; 48(2):453-64. PubMed ID: 12675804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
    Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Jacobs WR; Glatman-Freedman A; Larsen MH
    Vaccine; 2007 Nov; 25(45):7832-40. PubMed ID: 17931755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines.
    Olsen A; Chen Y; Ji Q; Zhu G; De Silva AD; Vilchèze C; Weisbrod T; Li W; Xu J; Larsen M; Zhang J; Porcelli SA; Jacobs WR; Chan J
    mBio; 2016 May; 7(3):. PubMed ID: 27247233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.
    Feng CG; Palendira U; Demangel C; Spratt JM; Malin AS; Britton WJ
    Infect Immun; 2001 Jun; 69(6):4174-6. PubMed ID: 11349095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages.
    Sullivan JT; Young EF; McCann JR; Braunstein M
    Infect Immun; 2012 Mar; 80(3):996-1006. PubMed ID: 22215736
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
    Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
    Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
    Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
    Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.